NeuroMetrix (NURO) - Get NeuroMetrix, Inc. Report shares were soaring in premarket trading Friday as the company was touted by the retail investing crowd.
NeuroMetrix climbed nearly 30% to $12.80.
"$NURO the more volume we get the more we go down.. everyone is profit taking bigly," one Stocktwits poster said Friday morning.
NeuroMetrix shares took off in July when the Food and Drug Administration gave a "Breakthrough Designation" to the biopharma's Quell device for treating fibromyalgia in adults.
Quell is an advanced, non-invasive, nerve stimulation device that is covered by 18 U.S. utility patents, the company said.
https://www.thestreet.com/investing/support-sprt-stock-neurometrix-stocks-soar-meme-boost
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.